CREBBP and diffuse large B-cell lymphoma: Remarkably, combining genetic deletion of both genes prevented GC formation in vivo and impaired DLBCL proliferation in vitro, suggesting that DLBCLs with CREBBP mutations become biologically dependent on EP300 (Meyer et al., 2019).